Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 1
55
Views
1
CrossRef citations to date
0
Altmetric
Original Research: Cardiology

Impact of same-admission percutaneous coronary intervention on periprocedural outcomes of transcatheter aortic valve implantation

, MDORCID Icon, , PhD, , MD, , MD & , MD
Pages 7-13 | Received 16 May 2023, Accepted 09 Oct 2023, Published online: 07 Nov 2023

  • Carità P, Coppola G, Novo G, et al. Aortic stenosis: insights on pathogenesis and clinical implications. J Geriatr Cardiol. 2016;13:489–498.
  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35–e71. doi:10.1161/CIR.0000000000000932.
  • Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease—implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62(1):1–10. doi:10.1016/j.jacc.2013.01.096.
  • Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease [published correction appears in Eur Heart J. 2022 Feb 18]. Eur Heart J. 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395.
  • Park DY, An S, Arif AW, Vij A. C-47: Periprocedural outcomes after same-admission transcatheter aortic valve implantation and percutaneous coronary intervention. J Soc Cardiovasc Angiog Intervent. 2022;1(3):100199. doi:10.1016/j.jscai.2022.100199.
  • Cao D, Chiarito M, Pagnotta P, Reimers B, Stefanini GG. Coronary revascularisation in transcatheter aortic valve implantation candidates: why, who, when? Interv Cardiol. 2018;13(2):69–76. doi:10.15420/icr.2018:2:2.
  • HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2021.
  • Ghrair F, Omran J, Thomas J, et al. Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement. Arch Med Sci Atheroscler Dis. 2020;5(1):e284–e289. doi:10.5114/amsad.2020.103092.
  • Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous coronary intervention versus transcatheter aortic valve replacement alone in the United States. Am J Cardiol. 2016;118(11):1698–1704. doi:10.1016/j.amjcard.2016.08.048.
  • Mohamed MO, Polad J, Hildick-Smith D, et al. Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry. EuroIntervention. 2020;16(7):603–612. doi:10.4244/EIJ-D-20-00361.
  • Doll JA, Hira RS, Kearney KE, et al. Management of percutaneous coronary intervention complications: algorithms from the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference. Circ Cardiovasc Interv. 2020;13:e008962.
  • Mentias A, Desai MY, Saad M, et al. Incidence and outcomes of acute coronary syndrome after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020;13(8):938–950. doi:10.1016/j.jcin.2019.11.027.
  • Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6:1–27.
  • Patterson T, Clayton T, Dodd M, et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION). JACC Cardiovasc Interv. 2021;14(18):1965–1974. doi:10.1016/j.jcin.2021.06.041.
  • Wenaweser P, Pilgrim T, Guerios E, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7(5):541–548. doi:10.4244/EIJV7I5A89.
  • Park DY, Simonato M, Ahmad Y, Banks AZ, Lowenstern A, Nanna MG. Insight into the optimal timing of percutaneous coronary intervention and transcatheter aortic valve replacement. Curr Probl Cardiol. 2023;49(1 Pt A):102050. doi:10.1016/j.cpcardiol.2023.102050.
  • Faroux L, Lhermusier T, Vincent F, et al. ST-Segment elevation myocardial infarction following transcatheter aortic valve replacement. J Am Coll Cardiol. 2021;77(17):2187–2199. doi:10.1016/j.jacc.2021.03.014.
  • Gruberg L, Gandotra P. STEMI Following TAVR: Unusual but definitely not trivial. J Am Coll Cardiol. 2021;77(17):2200–2203. doi:10.1016/j.jacc.2021.03.300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.